Completed PHASE4 INTERVENTIONAL 1-arm NCT01465438

HUmira in Psoriatic Arthritis (HUPSA)

Can New Imaging- and Biomarkers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Psoriatic Arthritis Patients Receiving Adalimumab?

Sponsor: Copenhagen University Hospital at Herlev

Conditions Psoriatic Arthritis

Interventions Adalimumab

Updated 6 times since 2017 Last updated: Nov 3, 2011 Started: Nov 30, 2006 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Psoriatic Arthritis, this trial is completed. The trial is conducted by Copenhagen University Hospital at Herlev and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Copenhagen University Hospital at Herlev
Copenhagen University Hospital, Hvidovre
Glostrup University Hospital, Copenhagen
University Hospital, Gentofte, Copenhagen

Data source: Glostrup University Hospital, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glostrup Municipality, Denmark